Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.
Current Team (10)Update
Chief Medical Officer
VP, Clinical Research
VP of Quality Assurance
Chief Financial Officer & SVP Corporate Development
SVP of Product Development
VP of Regulatory
Past Team (2)Update
Funding Rounds (4) - $82MUpdate
Board Members and Advisors (5)Update
Global Private Equity & Venture Capital
For 30 years the Mohr Davidow Ventures (MDV) team has invested in early stage technology-based...
The DAG (Duff Ackerman & Goodrich) Ventures partnership began with investments in the cable...
Aeris Capital AG is a private equity fund and financial advisor with locations in the United...
1900 Powell Street
Emeryville, CA 94608
- 04/10/14 -nasdaq.com